Anhui Huangshan Capsule Co Ltd - Asset Resilience Ratio
Anhui Huangshan Capsule Co Ltd (002817) has an Asset Resilience Ratio of 4.78% as of December 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Anhui Huangshan Capsule Co Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2022)
This chart shows how Anhui Huangshan Capsule Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Anhui Huangshan Capsule Co Ltd (002817) total assets.
Liquid Assets Composition Over Time
This chart breaks down Anhui Huangshan Capsule Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore investment intensity of Anhui Huangshan Capsule Co Ltd to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥49.58 Million | 4.78% |
| Total Liquid Assets | CN¥49.58 Million | 4.78% |
Asset Resilience Insights
- Limited Liquidity: Anhui Huangshan Capsule Co Ltd maintains only 4.78% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Anhui Huangshan Capsule Co Ltd Industry Peers by Asset Resilience Ratio
Compare Anhui Huangshan Capsule Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Beijing Tongrentang Co Ltd
SHG:600085 |
Drug Manufacturers - Specialty & Generic | 0.50% |
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Neuland Laboratories Limited
NSE:NEULANDLAB |
Drug Manufacturers - Specialty & Generic | 9.65% |
|
China Resources Double-Crane Pharmaceutical Co Ltd
SHG:600062 |
Drug Manufacturers - Specialty & Generic | 1.18% |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267 |
Drug Manufacturers - Specialty & Generic | 0.01% |
Annual Asset Resilience Ratio for Anhui Huangshan Capsule Co Ltd (2016–2022)
The table below shows the annual Asset Resilience Ratio data for Anhui Huangshan Capsule Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2022-12-31 | 4.78% | CN¥49.58 Million ≈ $7.25 Million |
CN¥1.04 Billion ≈ $151.85 Million |
-1.40pp |
| 2021-12-31 | 6.18% | CN¥65.14 Million ≈ $9.53 Million |
CN¥1.05 Billion ≈ $154.21 Million |
-4.71pp |
| 2020-12-31 | 10.89% | CN¥99.77 Million ≈ $14.60 Million |
CN¥915.81 Million ≈ $134.01 Million |
+1.09pp |
| 2019-12-31 | 9.80% | CN¥81.54 Million ≈ $11.93 Million |
CN¥831.80 Million ≈ $121.72 Million |
-2.38pp |
| 2017-12-31 | 12.18% | CN¥90.00 Million ≈ $13.17 Million |
CN¥738.73 Million ≈ $108.10 Million |
-10.70pp |
| 2016-12-31 | 22.88% | CN¥160.00 Million ≈ $23.41 Million |
CN¥699.36 Million ≈ $102.34 Million |
-- |
About Anhui Huangshan Capsule Co Ltd
Anhui Huangshan Capsule Co., Ltd. engages in the research and development, production, and sale of gelatin and enteric-coated gelatin empty capsules in China. The company offers pullulan capsules, entersoluble vacant gelatin capsules, vacant gelatin capsules, vegetable entersoluble capsules, colonsoluble vacant gelatin capsules, hydroxypropyl methyl cellulose hollow capsules, and hydroxypropyl st… Read more